These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18398820)

  • 1. Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
    Shepherd CJ; Rizzo S; Ledaki I; Davies M; Brewer D; Attard G; de Bono J; Hudson DL
    Prostate; 2008 Jun; 68(9):1007-24. PubMed ID: 18398820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
    Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
    Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
    Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
    Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
    Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M
    BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
    Brown MD; Gilmore PE; Hart CA; Samuel JD; Ramani VA; George NJ; Clarke NW
    Prostate; 2007 Sep; 67(13):1384-96. PubMed ID: 17639507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
    Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
    Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
    Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
    Goodyear SM; Amatangelo MD; Stearns ME
    Prostate; 2009 May; 69(7):689-98. PubMed ID: 19143028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
    Liu G; Yuan X; Zeng Z; Tunici P; Ng H; Abdulkadir IR; Lu L; Irvin D; Black KL; Yu JS
    Mol Cancer; 2006 Dec; 5():67. PubMed ID: 17140455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
    Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells.
    Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J; Jaatinen T
    Stem Cells Dev; 2006 Dec; 15(6):839-51. PubMed ID: 17253947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
    Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP
    Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.
    Zarkoob H; Taube JH; Singh SK; Mani SA; Kohandel M
    PLoS One; 2013; 8(5):e64169. PubMed ID: 23734191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and genetic characteristics of tumor-initiating cells in colon cancer.
    Ieta K; Tanaka F; Haraguchi N; Kita Y; Sakashita H; Mimori K; Matsumoto T; Inoue H; Kuwano H; Mori M
    Ann Surg Oncol; 2008 Feb; 15(2):638-48. PubMed ID: 17932721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent.
    Sun Y; Kong W; Falk A; Hu J; Zhou L; Pollard S; Smith A
    PLoS One; 2009; 4(5):e5498. PubMed ID: 19430532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.
    Yasuda H; Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Kawamoto A; Inoue Y; Miki C; Kusunoki M
    Oncol Rep; 2009 Oct; 22(4):709-17. PubMed ID: 19724847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
    Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
    Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.